Concepedia

Author

Graeme Fraser

McMaster UniversityORCID

Also Known As

G A M Fraser, G Fraser, G. A. M. Fraser, G. Fraser, G.A. Fraser, Graeme A Fraser, Graeme A M Fraser, Graeme A. Fraser, Graeme A. M. Fraser, Graeme A.M. Fraser

94

Publications

3.2K

Citations

22

H-Index

54

Concepts

All Affiliations

McMaster UniversityJuravinski Cancer CentreJanssen (United States)University of CologneMayo Clinic in Florida
GF

About

Graeme Fraser is an author at McMaster University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

735

2

Health Sciences

4

4

61

3

Public Health

2

2

139

4

Nursing

1

1

93

5

Blood Transplantation

1

1

22

Graeme Fraser

×

28

Publications

1.7K

Citations

17

H-Index

YearCitations

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Asher Chanan‐Khan, Paula Cramer, Fatih Demırkan,

The Lancet Oncology

2015

408

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials

Jennifer R. Brown, Javid J. Moslehi, Susan O’Brien,

Haematologica

2017

252

Principles and Recommendations for the Provision of Healthcare in Canada to Adolescent and Young Adult–Aged Cancer Patients and Survivors

Conrad V. Fernandez, Graeme Fraser, Carolyn Freeman,

Journal of Adolescent and Young Adult Oncology

2011

117

Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

Graeme Fraser, Paula Cramer, Rodrigo Santucci Alves da Silva,

Leukemia

2018

116

Lentivirus-mediated gene therapy for Fabry disease

Dwayne L. Barber, Ju Huang, C. Anthony Rupar,

Nature Communications

2021

115

Identifying the supportive care needs of adolescent and young adult survivors of cancer: a qualitative analysis and systematic literature review

Elena Tsangaris, Jessica L. Johnson, Rachel M. Taylor,

Supportive Care in Cancer

2013

93

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis

Jennifer R. Brown, Javid J. Moslehi, Michael S. Ewer,

British Journal of Haematology

2018

90

Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma

Susan O’Brien, Peter Hillmen, Steven Coutré,

Clinical Lymphoma Myeloma & Leukemia

2018

81

Helicobacter pylori infection and blood groups.

Yaron Niv, Graeme Fraser, G Delpré,

PubMed

1996

49

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group

Matthew D. Seftel, John Kuruvilla, Tom Kouroukis,

Leukemia & lymphoma/Leukemia and lymphoma

2016

47

Page 1